SEC Form 4 · accession 0001225208-19-000883
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Maulik Nanavaty
Officer — SVP & Pres, Neuromodulation
Period of report
Jan 15, 2019
Accepted (ET)
Jan 16, 2019 · 4:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jan 15, 2019 | M | 3,038 | $7.41 | A | 243,206 | D | |
| Common StockF2 | Jan 15, 2019 | S | 3,038 | $35.46 | D | 240,168 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $7.41 | Jan 15, 2019 | M | 3,038 | D | — | Feb 16, 2020 | Common Stock | 3,038 | 15,193 | D |
Explanation of responses
- F1This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
- F2Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- F3Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four annual increments beginning on February 16, 2011, the first anniversary of the grant.
Remarks
nanavatypoa.txt